Second PIC/S GMP Certification | Mabwell Passes Brazilian GMP Inspection for Its Denosumab Injections

RegulatoryapprovedDenosumab InjectionsPositive

AI Analysis

Summary

Mabwell's subsidiary T-mab has successfully passed Brazilian Health Regulatory Agency (ANVISA) GMP inspection for its Denosumab Injections, marking the company's second PIC/S GMP certification.

Outcome Details

Passed Brazilian GMP (Good Manufacturing Practice) inspection by ANVISA

Importance:5/10

Sentiment:

0.60

GMP certificationregulatory approvalBrazilmanufacturingdenosumab

Related Companies

$INBP $HIT

Read the original article

Published by PR Newswire Clinical Trials on August 10, 2026 12:00 AM

Read Original